Helen-angell
Associate Principal Scientist
Pharmaceutics
JHP Pharmaceuticals Llc
Lithuania
Biography
Helen Angell is an Associate Principal Scientist in the Oncology, Translational Science team in the IMED Biotech Unit in Cambridge, UK. Helen received her Ph.D. ‘Immune Modulation of the Tumour Microenvironment’ from the University of Nottingham School of Pharmacy, funded by AstraZeneca and EPSRC (Engineering and Physical Sciences Research Council). Upon completing her doctorate, Helen began working in the Laboratory of Integrative Immunology at the Cordeliers Research Centre, Paris.
Research Interest
Pharmaceutics
